Skip to content
10-Q

Quarterly Report

HYPERTENSION DIAGNOSTICS INC /MN

0001058828-13-000010

← back to feed
Filed
Feb 14, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2013 · Dec 31, 2012 59.73M sh
Shares Diluted Q2 2013 · Dec 31, 2012 59.73M sh
Shares Outstanding Q2 2013 · Dec 31, 2012 52.39M sh
Capex Q2 2013 · Dec 31, 2012 −$75.87K
Stockholders Equity Q2 2013 · Dec 31, 2012 −$896.99K
Stockholders Equity Q2 2013 · Jun 30, 2012 −$288.67K
Current Liabilities Q2 2013 · Dec 31, 2012 $798.82K
Current Liabilities Q2 2013 · Jun 30, 2012 $654.83K
Total Liabilities Q2 2013 · Dec 31, 2012 $1.9M
Total Liabilities Q2 2013 · Jun 30, 2012 $1.59M
Current Assets Q2 2013 · Dec 31, 2012 $352.69K
Current Assets Q2 2013 · Jun 30, 2012 $576.45K
Total Assets Q2 2013 · Dec 31, 2012 $1M
Total Assets Q2 2013 · Jun 30, 2012 $1.31M
Eps Diluted Q2 2013 · Dec 31, 2012 $0.00
Eps Diluted Q2 2013 · Dec 31, 2012 −$0.02
Eps Basic Q2 2013 · Dec 31, 2012 $0.00
Eps Basic Q2 2013 · Dec 31, 2012 −$0.02
Sga Expense Q2 2013 · Dec 31, 2012 $117.96K
Sga Expense Q2 2013 · Dec 31, 2012 $318.98K
Net Income Q2 2013 · Dec 31, 2012 −$42.5K
Net Income Q2 2013 · Dec 31, 2012 −$772.34K
Operating Income Q2 2013 · Dec 31, 2012 −$362.2K
Operating Income Q2 2013 · Dec 31, 2012 −$755.28K
Gross Profit Q2 2013 · Dec 31, 2012 −$244.87K
Gross Profit Q2 2013 · Dec 31, 2012 −$356.32K
Cost Of Revenue Q2 2013 · Dec 31, 2012 −$258.3K
Cost Of Revenue Q2 2013 · Dec 31, 2012 −$404.38K
Revenue Q2 2013 · Dec 31, 2012 $13.44K
Revenue Q2 2013 · Dec 31, 2012 $48.06K
Cash And Equivalents Q2 2013 · Jun 30, 2012 $75.04K